T-Cells Identified as Triggers of Brain Damage in Alzheimer’s; Blocking Them Preserves Mental Function

Breakthrough in Understanding Alzheimer’s Disease

According to НВ — Техно: Scientists have uncovered the mechanism responsible for brain cell damage in Alzheimer’s disease. A study led by Dr. David Holtzman at Washington University School of Medicine in St. Louis revealed that T-cells, activated by type 1 classical dendritic cells (cDC1) in lymph nodes, play a crucial role in initiating this destructive process. Experiments conducted on lab mice showed that removing dendritic cells from lymph nodes halted the abnormal migration of T-cells into the brain.

Interrupting this pathway significantly reduced neurodegeneration and preserved cognitive abilities in the animals, even though the levels of tau protein within the brain remained unchanged. This discovery points to new therapeutic opportunities targeting peripheral immune responses. Researchers are exploring these immune system interactions as a promising route towards developing safer and simpler treatments for Alzheimer’s disease, a condition that affects millions worldwide.

Advancing Toward New Treatment Options

Efforts are ongoing to identify specific signaling markers that guide T-cells to the brain. The research team is also investigating whether intervening during middle age can halt Alzheimer’s progression. The findings were published in a major study, with the news released on September 28 at 14:03.

These findings open new avenues for both understanding and treating Alzheimer’s disease.

If confirmed through further research, this work may lead to innovative therapies aimed at the body’s immune system, offering hope for more effective and safer management of neurodegenerative disorders. Given the increasing global prevalence of Alzheimer’s, these studies are vital to advancing medical approaches against this challenging disease.

In addition to the role of T-cells in brain damage, recent research has also highlighted the involvement of specific proteins in the integrity of the blood-brain barrier. Understanding how fibronectin contributes to barrier disruption could further illuminate the complex mechanisms behind Alzheimer's disease, paving the way for comprehensive treatment strategies.